Male
Expertise
Breast Cancer, Medical Oncology
Research Interests
Breast Cancer
William Albert Houck III, M.D.
Education
Degrees
- MD; Virginia Commonwealth University School of Medicine (1998)
Residencies
- Internal Medicine; Mayo Clinic (2001)
Fellowships
- Hematology and Oncology; Indiana University School of Medicine (2004)
Board Certifications
- American Board of Internal Medicine (Hematology) (2004)
- American Board of Internal Medicine (Internal Medicine) (2001)
- American Board of Internal Medicine (Medical Oncology) (2004)
Research & Publications
Clinical Trial Keywords
Breast Cancer Clinical Trials
Selected Publications
Houck W, Abonour R, Vance G, Einhorn L. Secondary leukemias in refractory germ cell tumor patients undergoing autologous stem-cell transplantation using high-dose etoposide. J Clin Onc 22:2155-2158, 2004Houck W, Einhorn L. Secondary leukemias in germ cell tumor patients undergoing autologous stem cell transplant utilizing high dose etoposide. Proc Am Soc Clin Oncol 22:390, 2003 (abstr 1566)
Houck W, Miller K, Schneider B. Targeting HER2, EGFR, and VEGF in breast cancer; therapeutic potential and current results. Medscape Hematology-Oncology eJournal. 2003 Jan 27
Schneider B, Houck W, Sledge G. Targeted Therapy in Breast Cancer. Diseases of the Breast Updates. 6 (3), 1-13, 2003
Houck WA, Soares-Welch CV, Montori VM, Li JT. Learning the thyroid examination a multimodality intervention for internal medicine residents. Teach Learn Med 14(1):24-8, 2002 Winter
Activities & Honors
Memberships
- American Society of Clinical Oncology
- Medical Society of Virginia
- Virginia Association of Hematologists and Oncologists
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.